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Abstract
Introduction: Current monitoring during cardiopulmonary resuscitation (CPR) is limited to clinical observation of
consciousness, breathing pattern and presence of a pulse. At the same time, the adequacy of cerebral oxygenation
during CPR is critical for neurological outcome and thus survival. Cerebral oximetry, based on near-infrared
spectroscopy (NIRS), provides a measure of brain oxygen saturation. Therefore, we examined the feasibility of using
NIRS during CPR.
Methods: Recent technologies (FORE-SIGHT™ and EQUANOX™) enable the monitoring of absolute cerebral tissue
oxygen saturation (SctO2) values without the need for pre-calibration. We tested both FORE-SIGHT™ (five patients)
and EQUANOX Advance™ (nine patients) technologies in the in-hospital as well as the out-of-hospital CPR setting.
In this observational study, values were not utilized in any treatment protocol or therapeutic decision. An
independent t-test was used for statistical analysis.
Results: Our data demonstrate the feasibility of both technologies to measure cerebral oxygen saturation during
CPR. With the continuous, pulseless near-infrared wave analysis of both FORE-SIGHT™ and EQUANOX™
technology, we obtained SctO2 values in the absence of spontaneous circulation. Both technologies were able to
assess the efficacy of CPR efforts: improved resuscitation efforts (improved quality of chest compressions with
switch of caregivers) resulted in higher SctO2 values. Until now, the ability of CPR to provide adequate tissue
oxygenation was difficult to quantify or to assess clinically due to a lack of specific technology. With both
technologies, any change in hemodynamics (for example, ventricular fibrillation) results in a reciprocal change in
SctO2. In some patients, a sudden drop in SctO2 was the first warning sign of reoccurring ventricular fibrillation.
Conclusions: Both the FORE-SIGHT™ and EQUANOX™ technology allow non-invasive monitoring of the cerebral
oxygen saturation during CPR. Moreover, changes in SctO2 values might be used to monitor the efficacy of CPR
efforts.
Introduction
Monitoring the adequacy of oxygenation and circulation
in patients during cardiopulmonary resuscitation (CPR)
and advanced life support (ALS) remains a major chal-
lenge. Monitoring is limited to clinical observation of con-
sciousness, pulse and breathing pattern [1]. During CPR
and ALS, pulse oximetry and non-invasive blood pressure
measurement are unreliable. Additionally, an intermittent
(every two minutes) rhythm check with electrocardiogra-
phy (ECG)-electrodes or defibrillator paddles necessitates
interruption of chest compressions. Currently, end-tidal
CO2 measurement is the best technique to monitor ade-
quate circulation; it will increase sharply on return of
spontaneous circulation (ROSC). However, end-tidal CO2
can only be used in the intubated patient, is dependent on
the ventilatory strategy and does not give information on
the adequacy of cerebral oxygenation.
An ‘ideal’ parameter to monitor the adequacy of oxy-
genation and circulation during CPR and ALS would
have the following characteristics: easily (non-invasively)
measured, continuous rather than intermittent informa-
tion, and neither requirement of pulsatile flow nor inter-
ruption of chest compressions. Last but not least, it
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should provide information on the oxygenation of vital
organs (heart, kidney, brain).
Cerebral oximetry, based on near-infrared spectroscopy
(NIRS) technology, provides information on brain oxyge-
nation and the adequacy of cerebral perfusion [2]. It
measures regional cerebral oxygen saturation at the micro-
vascular level (arterioles, venules and capillaries) [3-8].
There have been previous efforts to use cerebral oximetry
during CPR with conflicting results [9-11]. Recent devel-
opments allow the monitoring of absolute cerebral tissue
oxygen saturations (SctO2), without the need for calibra-
tion (FORE-SIGHT™ technology) [12]. The EQUANOX
Advance™ uses similar technology [13], but has the
advantage of being portable and as such is more user
friendly in the pre-hospital setting. Moreover, the EQUA-
NOX™ technology reveals minimal extracranial contami-
nation compared to other commercially available NIRS
technologies [14]. Because of these promising properties
(absolute saturation monitoring and transportable moni-
toring device), we tested the feasibility of both technolo-
gies in the CPR setting.
Materials and methods
In this observational study, data on cerebral tissue oxygen
saturation was collected during in- and out-of-hospital
cardiac arrest. The SctO2 values were not blinded to the
attending emergency physicians but were not used in any
treatment protocol or therapeutic decision. The study
was approved by the Committee for Medical Ethics,
Ziekenhuis Oost-Limburg, Genk, Belgium. Requirement
for informed patient consent was waived because of the
emergency setting.
Cerebral tissue oxygen saturation
Two emergency physicians, members of the medical emer-
gency intervention team, used non-invasive cerebral moni-
toring during ALS for patients suffering from cardiac
arrest (CA). Initially, a FORE-SIGHT™ monitor (CAS
Medical Systems, Branford, CT, USA) was transported to
the scene of CA. Due to its weight (9.8 kg), a third person,
not taking part in the medical rescue intervention, carried
the monitor. On arrival, bilateral NIRS sensors were
applied on the patient’s forehead. From December 2011
on, the EQUANOX Advance™ monitor (Nonin Medical
Inc., Plymouth, MN, US) was used. Since this monitor is
light (0.9 kg) and easily transportable, aid from a third per-
son was not necessary. To minimize time delay, only one
sensor was applied on the patient’s right forehead. With
both monitoring devices, SctO2 values were electronically
collected from arrival until termination of CPR (or until
transfer to the emergency unit of the hospital). With both
technologies, protective adhesive tape was applied over the
sensor(s) in order to minimize possible external light
interference.
Cardiopulmonary resuscitation
Resuscitation procedures were performed in accordance
with the Guidelines of the European Resuscitation Coun-
cil. During ALS, patients were monitored with three-lead
ECG and end tidal CO2 (ETCO2). Once ROSC had been
established, pulse oximetry and non-invasive blood pres-
sure were monitored. In one patient, suffering from in-
hospital cardiac arrest, invasive blood pressure monitor-
ing was available during ALS.
Statistical analysis
Statistical analysis was performed using SPSS V19.0
(SPSS Inc, Chicago, IL, USA). Equal distribution was
tested using the Kolmogorov-Smirnov test. Values for
cerebral oxygen saturation at each time point were com-
pared using the independent t-test. The results are repre-
sented as mean (± standard deviation). A P-value below
0.05 was considered statistically significant.
Results and discussion
In sixteen 16 cardiac arrest patients, NIRS monitoring was
applied during CPR (five with FORE-SIGHT™and eleven
with EQUANOX Advance™ technology). Relevant differ-
ences between the two technologies are listed in Table 1.
In two patients (EQUANOX™), it was impossible to
obtain a value within the first three minutes of monitoring,
and no further attempts were made to monitor SctO2.
Therefore, the results of only 14 patients will be reported.
Three of the five patients monitored with the FORE-
SIGHT™ monitor suffered from in-hospital cardiac arrest
(IHCA), while the majority of patients (seven out of nine)
monitored with the EQUANOX™ monitor suffered from
out-of-hospital cardiac arrest (OHCA). Two patients (both
OHCA victims) monitored with the FORE-SIGHT™
monitor survived (ROSC >20 minutes). ROSC was obser-
ved in four patients (three OHCA and one IHCA) moni-
tored with the EQUANOX™ monitor (Table 2).







Weight (kg) 0.9 9.8
Time to first value (seconds) ± 10 ± 32
Response time (seconds) 4 2
Battery time (hours) >3 1.5
Extracranial contaminationa 6.8% ± 6 11.8% ± 5.3
Trouble shoot menu no yes
aExtracranial contamination was determined as a decrease in cerebral oxygen
saturation during inflation of a pneumatic head cuff compared to baseline
values [14].
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With both technologies, stable NIRS signals and reli-
able SctO2 values were obtained within the first minute
of sensor application, except for both patients previously
described and excluded from further analysis.
Starting SctO2 values (during basic life support) were
between 0% and 51%, with a mean value of 27% (± 19)
(Table 2). Mean starting SctO2 for IHCA was 34% (± 22)
whereas mean starting SctO2 in OHCA was 23% (± 17),
which was not statistically significant (P = 0.296). Mean
starting SctO2 in survivors was 29% (± 15) which was not
significantly different from mean SctO2 in non-survivors
(25% ± 22) (P = 0.748). Mean time of CPR before the
first SctO2 value was monitored was 29 minutes (± 9) in
OHCA patients and 16 minutes (± 6) in IHCA patients
(Table 3).
The highest SctO2 values observed during CPR efforts
were between 10% and 61%, with a mean value of 44%
(± 15). Highest SctO2 values during CPR were neither sig-
nificantly different between OHCA patients (41% ± 15)
and IHCA patients (48% ± 15; P = 0,442) nor between sur-
vivors (43% ± 18) and non-survivors (45 ± 13; P = 0.778)
of CA.
ROSC >20 minutes (survivors) was observed in six
patients (five OHCA, one IHCA). In the five OHCA
patients, highest SctO2 values after ROSC were between
51% and 73% with a mean value of 62% (± 8). The only
IHCA-survivor showed SctO2 values of 81% after ROSC.
In these CA-survivors, SctO2 values before transfer to the
emergency unit were between 46% and 67% with a mean
SctO2 value of 57% (± 10).
In OHCA patients where any further CPR effort was ter-
minated, SctO2 values at the stop of CPR were between 0
and 36%, with a mean SctO2 value of 18% (± 16). In IHCA
patients, SctO2 values were between 8% and 41% (mean
30% ±15) when CPR was stopped, which was not different
from the OHCA patients (P = 0.311) (Table 2). SctO2
values at the end of CPR were significantly lower (P =
0.001) in patients not surviving CA compared with those
who were transferred to the emergency unit.
As SctO2 monitoring during CPR provides continuous
information during extremely difficult and rapidly changing
conditions, relevant information from SctO2 during the





ROSC? Start value SctO2
(%)
Highest SctO2 (%) during
CPR




1 OH FS Yes 33 38 73 67
4 OH FS Yes 44 53 61 60
6 IH EQ Yes 15 58 81 82
11 OH EQ Yes 40 41 51 47
13 OH EQ Yes 5 10 58 65

















Highest SctO2 (%) during
CPR
Highest SctO2 (%) during
ROSC
SctO2 (%) at end CPR
2 IH FS No 47 45 36
3 IH FS No 52 61 35
5 IH FS No 51 52 41
7 OH EQ No 3 38 0
8 OH EQ No 14 61 11
9 IH EQ No 7 24 8
10 OH EQ No 0 35 25









EQ, Equanox Advance technology; FS, Fore-Sight technology; IH, in-hospital cardiac arrest; OH, out-of-hospital cardiac arrest; ROSC, return of spontaneous
circulation; SctO2, regional cerebral tissue oxygen saturation.




Number 14 9 5




Male, number 10 6 4
ROSC >20 minutes 6 5 1
Time between CA and first SctO2 value,
min.a
25 (10) 29 (9) 16 (6)
athe exact time frame is missing in a number of patients; results are
presented as mean (± SD). IHCA, in-hospital cardiac arrest; min., minutes;
OHCA, out-of-hospital cardiac arrest; ROSC, return of spontaneous circulation.
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CPR efforts is further elucidated by presenting the data of
four individual patients (Figures 1, 2, 3, and 4).
This is the first report on the use of the ForeSight™ and
EQUANOX Advance™ technology during in- and out-of-
hospital CPR. Both technologies use four precise infrared
wavelengths to maximize the accuracy of oxyhemoglobin
and de-oxyhemoglobin measurement and to enable abso-
lute oxygen saturation monitoring (and not just trend-only
monitoring). In a recent comparison of accuracy perfor-
mance (referring to weighted CO-oximeter reference
values), the FORE-SIGHT™ monitor measured cerebral
oxygenation most precisely, followed by the EQUANOX
Advance™ monitor [15], providing increased confidence
in the utilization of this technology in the CPR setting.
Due to the continuous, pulseless wave analysis of both
technologies, we were able to monitor the cerebral oxygen
saturation in nine OHCA-patients and five IHCA-patients
during CPR with two different NIRS devices. The most
important difference between the technologies is the
respective weight of the monitors. The EQUANOX™
monitoring device is light (0.9 kg) and, therefore, the most
suited for use during out-of-hospital CPR.
Newman et al. already assessed the feasibility of NIRS to
measure cerebral perfusion during OHCA [9]. However,
they rarely detected cerebral perfusion or cerebral oxygen
saturation using the Invos-3000® technology during CPR.
A longer time interval from arrest to initial cerebral
oxygen saturation measurements may partially explain the
difference between their OHCA report and previous
experience during in-hospital CPR [10,11].
Recently, several papers were dedicated to the use of
INVOS®-NIRS technology in the post-CA area, indicat-
ing its potential role in predicting survival and neurolo-
gical outcome after CA. One of the earliest, although
small, OHCA studies demonstrated that all patients sur-
viving for one week achieved a significantly higher med-
ian rSO2 (regional brain oxygen saturation) during CPR
efforts than non-survivors [16]. Also, Ito et al. moni-
tored rSO2 (INVOS
® technology) and noted that any
rSO2 value below 25%, observed on hospital admission
in a post-CA patient without ROSC (despite continued
CPR efforts), could be interpreted as a potential indica-
tor of futile resuscitation attempts [17,18]. Kämäräinen
et al. reported on rSO2 (INVOS
® technology) and con-
cluded that improving CPR quality did not result in a
significant increase in rSO2 [19]. It should be noted that
they described substantial difficulties in reliable record-
ings of rSO2 data with INVOS 5100C
® technology as
59% of their 30-second data had artifacts making quan-
tification of rSO2 impossible. Most recently, Parnia et al.
(using INVOS®) concluded that IHCA-patients with
ROSC had an rSO2 above 30% for >50% of their CPR
duration, whereas non-survivors had an rSO2 that was
below 30% for >50% of their CPR period [20,21]. It
therefore stands to reason that cerebral oximetry may
have a role in predicting ROSC and the optimization of
cerebral oxygenation during cardiac arrest.
Figure 1 Cerebral tissue oxygen saturation (SctO2 (%))
(monitored with FORE-SIGHT™ technology) during out-of-
hospital cardiac arrest (patient 1). After 15 minutes of BLS, first
measured SctO2 values were 31% and 38% over the left (grey line)
and right (black line) fontal region, respectively. Defibrillation
(dotted arrow) resulted in ROSC and an immediate increase in SctO2
to 60% (left) and 69% (right). During preparation for transport,
ventricular fibrillation (arrow) reoccurred and was accompanied with
an immediate decrease in SctO2. Again, defibrillation (dotted arrow)
resulted in sinus rhythm and SctO2 values above 65%. BLS, basic life
support; CPR, cardiopulmonary resuscitation; Defib, defibrillation; VF,
ventricular fibrillation.
















Figure 2 Cerebral tissue oxygen saturation (SctO2 (%))
(monitored with EQUANOX Advance™ technology) in a patient
(patient 6) who collapsed at ER entrance. The sensor was applied
after six minutes of CPR and two defibrillation attempts. SctO2
started at 50% and increased to 60%, right before ventricular
fibrillation reoccurred (arrows). When ROSC was achieved, SctO2
increased immediately above 70%. CPR, cardiopulmonary
resuscitation; ROSC, return of spontaneous circulation; VF, ventricular
fibrillation.
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Figure 3 Cerebral tissue oxygen saturation (SctO2 (%)) (monitored with FORE-SIGHT™ technology) and arterial blood pressure
(mmHg) in an in-hospital cardiac arrest patient (patient 3). After 14 minutes of BLS by a trained caregiver, first measured SctO2 values were
48% and 52% over the left (grey line) and right (black line) fontal region, respectively. Switch of person giving CPR (arrows) resulted in increased
cerebral oxygen saturations. Parallel fluctuations were observed between SctO2 and systolic blood pressure (thin black line). After cessation of
CPR, SctO2 decreased to values between 30% and 35%. BLS, basic life support; CPR, cardiopulmonary resuscitation.
Figure 4 Cerebral tissue oxygen saturation (SctO2 (%)) (monitored with EQUANOX Advance™ technology) during out-of-hospital
cardiac arrest (patient 7). The starting SctO2 value (after 20 minutes of BLS) was 3%, but rose quickly to 21%. The highest measured value
during CPR was 38%. A decrease in SctO2 was observed during rhythm assessment (every 2 minutes). CPR was stopped 50 minutes after arrival
of the medical emergency team, without obtaining ROSC. After termination of CPR, SctO2 decreased rapidly. BLS, basic life support; CPR,
cardiopulmonary resuscitation; ROSC, return of spontaneous circulation.
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In our 14 patients, starting SctO2 values were between
0% and 52%. This high variability could be explained by
the fact that we measured both IHCA and OHCA patients
and that there was a high variability in time from collapse
to the first monitored SctO2 value in both groups. Further-
more, not all CPR characteristics were available for all
patients. Surprisingly, when using the EQUANOX
Advance™ monitor, a starting value of 0% SctO2 was
observed in one patient and an end-of-CPR value of 0% in
another patient. Whereas the EQUANOX Advance™
monitor displays these SctO2 values of 0%, the lowest
SctO2 value observed with the FORE-SIGHT™ monitor
was around 30%. Due to the proprietary algorithms behind
both cerebral oximetry monitors it is impossible to provide
any further explanation at present. More data are needed
to elucidate the exact significance of these extremely low
values and to exclude any possible interference from tech-
nical artifacts.
We observed an immediate increase in SctO2 after
ROSC and found significantly higher SctO2 values in
patients with permanent ROSC compared to patients in
whom no further CPR effort was continued. Further-
more, in four of our patients, new episodes of ventricular
fibrillation (Figures 1 and 2) were immediately noted on
the SctO2 monitoring, as an extra monitoring device
indicated this life-threatening situation with urgent need
for CPR.
SctO2 monitoring provides not only a tool for continu-
ous estimation of cerebral oxygenation during the status of
no ROSC, but also the ability to assess the efficacy of CPR
efforts. We observed parallel increases in systolic arterial
pressure during CPR and in SctO2 (Figure 3), illustrating
the positive effect of CPR on systolic blood pressure and
on cerebral oxygenation. Switch of caregivers during
mechanical chest compression, resulted in increased systo-
lic blood pressure and SctO2 (Figure 3). The immediate
effect of efficient CPR on cerebral oxygenation is illu-
strated in the rapid decrease in SctO2 during rhythm ana-
lysis (and consequent interruption of CPR) (Figure 4).
Limitations of this study include the small number of
patients, which makes it difficult to reach a conclusion
on the exact value of SctO2 in CA patients. A second lim-
itation is the fact that we used two different technologies
(FORE-SIGHT™ and EQUANOX Advance™). Although
both technologies use four wavelengths and display abso-
lute saturation values (without need for calibration), they
do use different (proprietary) algorithms to display their
calculated SctO2 values. The EQUANOX Advance™ oxi-
meter is shown to have less contamination of extracranial
vessels compared with the FORE-SIGHT™ oximeter
[14], but for both oximeters, accuracy is without doubt
acceptable [15]. These differences in algorithms can
probably be used to explain the different values displayed
in extreme conditions. The major limitation of this study
was that it was designed as a pilot feasibility study and
that not all patient or CPR characteristics are available. A
future, randomized, multicenter study will be initiated on
the use of NIRS during CPR with the inclusion of all CPR
data following the Utstein CPR data registration. Finally,
larger and properly designed studies will have to eluci-
date the potential role of SctO2 monitoring during CPR.
Conclusions
In conclusion, using FORE-SIGHT™ and EQUANOX™
technology, it is possible to monitor the SctO2 during
CPR after IHCA and OHCA. Moreover, changes in cer-
ebral oxygen saturation seem to vary with the quality of
chest compressions reflecting changes in cerebral oxyge-
nation. Future studies on the prognostic role of cerebral
oximetry during CPR are needed.
Key messages
• NIRS technologies allow measurement of SctO2
during CPR.
• These technologies may in the future prove to ful-
fill the need for better monitoring during CPR.
• SctO2 values are the earliest warning signs of
impending changes in cerebral oxygenation during/
after CPR.
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